Vascular Biogenics

A Look at Four Brain Cancer Companies for 2016
Yahoo
Mon, 01/4/16 - 12:24 pm
brain cancer
Del Mar
ImmunoCellular Therapeutics
Vascular Biogenics
Burzynski Research Institute
How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer
24/7 Wall St
Sun, 06/7/15 - 10:07 am
biotech
ASCO
Immunogen
Exelixis
Oncothyreon
CTI BioPharma
Immunomedics
Vascular Biogenics
16 Biotech Stocks Moving Off The ASCO Conference
Yahoo/Benzinga
Tue, 06/2/15 - 10:06 am
biotech
ASCO
Bristol-Myers Squibb
Immunogen
Oncothyreon
Clovis Oncology
CTI BioPharma
Exelixis
Roche
Amgen
AstraZeneca
Puma Biotechnology
Vascular Biogenics
Immunomedics
Momenta
Eli Lilly
Juno Therapeutics
Express Scripts
6 Key Cancer Winners From ASCO Presentations
24/7 Wall St
Mon, 06/1/15 - 10:06 am
ASCO
Immunogen
mirevtuximab soravtansine
ONT-380
Oncothyreon
cabozantinib
Exelixis
VB-111
Vascular Biogenics
Immunomedics
sacituzumab govitecan
pacritinib
CTI BioPharma
VBL's IPO falls apart as investor drops the ball
Fierce Biotech
Fri, 08/8/14 - 11:58 am
IPOs
Vascular Biogenics
Vascular Biogenics ($VBLX) trading halted, will IPO be reversed?
CP Wire
Thu, 08/7/14 - 06:19 pm
IPOs
Vascular Biogenics
Vascular Biogenics ($VBLX) trading halted, will IPO be reversed?
Thu, 08/7/14 - 06:18 pm
Vascular Biogenics
IPOs